(Q45378514)

English

Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy

scientific article published in April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Silvia Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Mark W Watson

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

James P Flexman

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Wendy Cheng

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Talia Hammond

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Patricia Price

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

publication date

1 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

82

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

568-574

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

TaqMan amplification system with an internal positive control for HCV RNA quantitation

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

The biology of human natural killer-cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

Simultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesions

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

CD56bright natural killer (NK) cells: an important NK cell subset.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

Interferon-gamma response by peripheral blood mononuclear cells to hepatitis C virus core antigen is reduced in patients with liver fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

Sustained response to interferon-alpha plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cells.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

Increased frequency of CD56Bright NK-cells, CD3-CD16+CD56- NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25High T-cells control potentially viremia in blood donors with HCV.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21742

21 January 2018

Identifiers

10.1002/JMV.21742

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45378514&oldid=2076267170"